<DOC>
	<DOCNO>NCT02644577</DOCNO>
	<brief_summary>The purpose study test efficacy metformin treatment antipsychotic-induced metabolic syndrome bipolar disorder patient .</brief_summary>
	<brief_title>Metformin Treatment Antipsychotic-induced Metabolic Syndrome Bipolar Disorder Patients</brief_title>
	<detailed_description>Patients age 18 45 year bipolar disorder diagnose accordance criterion set Diagnostic Statistical Manual Mental Disorders- Fourth Edition ( DSM-IV ) eligible study , Structured Clinical Interview DSM-IV Axis I Disorders ( SCID-1 ) , Clinical Version , use screen phase . To qualify study , patient meet , 1 ) experience metabolic syndrome define within first year treatment one four antipsychotics—clozapine , olanzapine , risperidone , sulpiride ; 2 ) either discharge inpatient unit first visit outpatient clinic 12 month enrollment , glucose lipid level , weight , blood pressure antipsychotic treatment document ; 3 ) take single antipsychotic medication , 25 % change dosage , past 3 month . All participant care parent another adult caregiver monitor recorded intake medication daily trial assure adherence medication . Patients exclude study evidence liver renal dysfunction , cardiovascular disease , diabetes mellitus ; pregnant lactating ; psychiatric diagnosis schizophrenia . The primary outcome level LDL-C percentage patient LDL-C great equal 3.37mmol/L ( 130mg/dl ) . The secondary outcome fast triglyceride , total cholesterol , HDL-C , insulin glucose level , insulin resistance index , body weight body mass index , well incidence adverse event . Body mass index calculate weight kilogram divide height meter square . Insulin resistance index calculate base homeostasis model assessment : fasting insulin ( mIU/L ) ×fasting glucose ( mmol/L ) /22.5 . assessment conduct member trained independent research team connect centre . Inclusion exclusion decide team . After complete description study subject , write informed consent obtain accordance National Health Medical Research Council guideline .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>clinical diagnosis bipolar disorder experience metabolic syndrome define within first year treatment one four antipsychotics—clozapine , olanzapine , risperidone , sulpiride either discharge inpatient unit first visit outpatient clinic 12 month enrollment , glucose lipid level , weight , blood pressure antipsychotic treatment document take single antipsychotic medication , 25 % change dosage , past 3 month must care parent another adult caregiver monitor recorded intake medication daily trial assure adherence medication psychiatric diagnosis schizophrenia liver dysfunction renal dysfunction cardiovascular disease diabetes mellitus pregnancy lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Metformin</keyword>
	<keyword>antipsychotic-induced metabolic syndrome</keyword>
	<keyword>bipolar disorder</keyword>
</DOC>